{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:28:55Z","timestamp":1787700535872,"version":"build-2784847793"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,29]],"date-time":"2011-10-29T00:00:00Z","timestamp":1319846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s10552-011-9860-2","type":"journal-article","created":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T02:11:44Z","timestamp":1319767904000},"page":"113-120","source":"Crossref","is-referenced-by-count":12,"title":["Hormone therapy and ovarian borderline tumors: a national cohort study"],"prefix":"10.1007","volume":"23","author":[{"given":"Lina Steinrud","family":"M\u00f8rch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"L\u00f8kkegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Helms","family":"Andreasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne Kr\u00fcger","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8jvind","family":"Lidegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,29]]},"reference":[{"issue":"1","key":"9860_CR1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00001703-200302000-00006","volume":"15","author":"MA Crispens","year":"2003","unstructured":"Crispens MA (2003) Borderline ovarian tumors: a review of the recent literature. Curr Opin Obstet Gynecol 15(1):39\u201343","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"5","key":"9860_CR2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/humupd\/dmm012","volume":"13","author":"CM Greiser","year":"2007","unstructured":"Greiser CM, Greiser EM, D\u00f6ren M (2007) Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis. Hum Reprod Update 13(5):453\u2013463","journal-title":"Hum Reprod Update"},{"issue":"9574","key":"9860_CR3","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(07)60534-0","volume":"369","author":"V Beral","year":"2007","unstructured":"Beral V, Million Women Study Collaborators, Bull D, Green J, Reeves G (2007) Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 369(9574):1703\u20131710","journal-title":"Lancet"},{"issue":"3","key":"9860_CR4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jama.2009.1052","volume":"302","author":"LS M\u00f8rch","year":"2009","unstructured":"M\u00f8rch LS, L\u00f8kkegaard E, Andreasen AH, Kr\u00fcger-Kjaer S, Lidegaard O (2009) Hormone therapy and ovarian cancer. JAMA 302(3):298\u2013305","journal-title":"JAMA"},{"issue":"3","key":"9860_CR5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/cncr.23956","volume":"115","author":"CL Pearce","year":"2009","unstructured":"Pearce CL, Chung K, Pike MC, Wu AH (2009) Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin. Cancer. 115(3):531\u2013539","journal-title":"Cancer."},{"issue":"2","key":"9860_CR6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cdp.2004.11.002","volume":"29","author":"PK Mills","year":"2005","unstructured":"Mills PK, Riordan DG, Cress RD, Goldsmith DF (2005) Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk. Cancer Detect Prev 29(2):124\u2013132","journal-title":"Cancer Detect Prev"},{"issue":"3","key":"9860_CR7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1006\/gyno.2001.6451","volume":"83","author":"T Riman","year":"2001","unstructured":"Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM et al (2001) Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Gynecol Oncol 83(3):575\u2013585","journal-title":"Gynecol Oncol"},{"issue":"4","key":"9860_CR8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/oxfordjournals.aje.a008937","volume":"144","author":"HA Risch","year":"1996","unstructured":"Risch HA, Marrett LD, Jain M, Howe GR (1996) Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case\u2013control study. Am J Epidemiol 144(4):363\u2013372","journal-title":"Am J Epidemiol"},{"issue":"11","key":"9860_CR9","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1080\/00016340701505523","volume":"86","author":"E L\u00f8kkegaard","year":"2007","unstructured":"L\u00f8kkegaard E, Lidegaard O, M\u00f8ller LN, Agger C, Andreasen AH, J\u00f8rgensen T (2007) Hormone replacement therapy in Denmark, 1995\u20132004. Acta Obstet Gynecol Scand 86(11):1342\u20131351","journal-title":"Acta Obstet Gynecol Scand"},{"key":"9860_CR10","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","volume":"339","author":"\u00d8 Lidegaard","year":"2009","unstructured":"Lidegaard \u00d8, L\u00f8kkegaard E, Svendsen AL, Agger C (2009) Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 339:b2890. doi: 10.1136\/bmj.b2890","journal-title":"BMJ"},{"issue":"4","key":"9860_CR11","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/pds.1549","volume":"17","author":"LH Nielsen","year":"2008","unstructured":"Nielsen LH, L\u00f8kkegaard E, Andreasen AH, Keiding N (2008) Using prescription registries to define continuous drug use: how to fill gaps between prescriptions. Pharmacoepidemiol Drug Saf 17(4):384\u2013388","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"9860_CR12","first-page":"535","volume":"44","author":"HH Storm","year":"1997","unstructured":"Storm HH, Michelsen EV, Clemmensen IH, Pihl J (1997) The Danish Cancer Register\u2013history, content, quality and use. Dan Med Bull 44(5):535\u2013539","journal-title":"Dan Med Bull"},{"issue":"1","key":"9860_CR13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/ije\/17.1.44","volume":"17","author":"HH Storm","year":"1988","unstructured":"Storm HH (1988) Completeness of cancer registration in Denmark 1943\u20131966 and efficacy of record linkage procedures. Int J Epidemiol 17(1):44\u201349","journal-title":"Int J Epidemiol"},{"key":"9860_CR14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00008469-200208000-00007","volume":"11","author":"AR Jensen","year":"2002","unstructured":"Jensen AR, Overgaard J, Storm HH (2002) Validity of breast cancer in the Danish Cancer Registry. A study based on clinical records from one county in Denmark. Eur J Cancer Prevent 11:359\u2013364","journal-title":"Eur J Cancer Prevent"},{"issue":"1","key":"9860_CR15","first-page":"50","volume":"169","author":"A Kjaerbye-Thygesen","year":"2007","unstructured":"Kjaerbye-Thygesen A, Huusom LD, Frederiksen K, Kjaer SK (2007) Danish cancer register and the pathology data bank. [Primary ovarian cancer. A comparison of registrations in the Danish Cancer Register and the Pathology Data Bank]. Ugeskr Laeger 169(1):50\u201354","journal-title":"Ugeskr Laeger"},{"issue":"6","key":"9860_CR16","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s10552-006-0022-x","volume":"17","author":"LD Huusom","year":"2006","unstructured":"Huusom LD, Frederiksen K, H\u00f8gdall EV, Glud E, Christensen L, H\u00f8gdall CK et al (2006) Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case\u2013control study. Cancer Causes Control 17(6):821\u2013829","journal-title":"Cancer Causes Control"},{"key":"9860_CR17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.maturitas.2004.05.011","volume":"51","author":"E Lokkegaard","year":"2005","unstructured":"Lokkegaard E, Eplov LF, Koster A, Garde K (2005) Cardiovascular risk factors in a cohort of Danish women born in 1936 prior to use of hormone therapy. Maturitas 51:221\u2013226","journal-title":"Maturitas"},{"issue":"7386","key":"9860_CR18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/bmj.326.7386.426","volume":"326","author":"E Lokkegaard","year":"2003","unstructured":"Lokkegaard E, Pedersen AT, Heitmann BL, Jovanovic Z, Keiding N, Hundrup YA et al (2003) Relation between hormone replacement therapy and ischaemic heart disease in women: prospective observational study. BMJ 326(7386):426\u2013431","journal-title":"BMJ"},{"key":"9860_CR19","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/cncr.20250","volume":"100","author":"A Tjonneland","year":"2004","unstructured":"Tjonneland A, Christensen J, Thomsen BL, Olsen A, Overvad K, Ewertz M et al (2004) Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study. Cancer 100:2328\u20132337","journal-title":"Cancer"},{"key":"9860_CR20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-5122(96)01065-1","volume":"25","author":"M Hammar","year":"1996","unstructured":"Hammar M, Brynhildsen J, Dabrosin L, Frisk J, Lindgren R, Nedstrand E et al (1996) Hormone replacement therapy and previous use of oral contraceptives among Swedish women. Maturitas 25:193\u2013199","journal-title":"Maturitas"},{"key":"9860_CR21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/j.1600-0412.2000.079003194.x","volume":"79","author":"YA Hundrup","year":"2000","unstructured":"Hundrup YA, Obel EB, Rasmussen NK, Philip J (2000) Use of hormone replacement therapy among Danish nurses in 1993. Acta Obstet Gynecol Scand 79:194\u2013201","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-011-9860-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-011-9860-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-011-9860-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T13:06:13Z","timestamp":1559221573000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-011-9860-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,29]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["9860"],"URL":"https:\/\/doi.org\/10.1007\/s10552-011-9860-2","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,29]]}}}